General Electric Co said &lt;BioReactorTechnology Inc> obtained its rights to an experimentaltechnique for analyzing blood samples to detect diseaseantibodies.    General Electric said BioReactor will attempt to developtest market kits from the advances made by General Electric.    General Electric said it granted the rights to BioReactorbecause the innovation, first announced in 1972, did not fitinto the company's long-range product plans.    In exchange for the patent, GE said it will receive anunspecified interest in the company.                Reuter&#3;